 This study is to determine the Maximal Tolerated Dose MTD, the Dose Limitant Toxicities DLTs and the safety profile of S-1 combined with fixed doses of Irinotecan SIRI schedule and fixed doses of Irinotecan and Oxaliplatin SIRINOX schedule. 